The current valuation score of Rezolute Inc is 6.24, ranking 320 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.80, which is -88.43% below the recent high of -0.67 and -101.98% above the recent low of -11.71.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.